Yanina Grant-Huerta
Chief Accounting Officer, Atara Biotherapeutics, Inc.
Companies
- ImageneBio, Inc.Chief financial officer Jul 28, 2026 to now1
- Atara Biotherapeutics, Inc.Chief Accounting Officer Apr 10, 2025 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atara Biotherapeutics, Inc. ATRA49,636 shares3$458.6K at $9.24May 18, 2026
- ImageneBio, Inc. IMA104,000 shares4$421.2K at $4.05Aug 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Granted 39,000 shares of ImageneBio, Inc.4
- Aug 14, 2026Granted 65,000 shares of ImageneBio, Inc.4
- May 18, 2026Sold 2,414 shares at $9.13 of Atara Biotherapeutics, Inc.3
- Mar 9, 2026Granted 20,300 shares of Atara Biotherapeutics, Inc.5
- Mar 2, 2026Sold 100 shares at $5.08 of Atara Biotherapeutics, Inc.6
- Mar 2, 2026Sold 377 shares at $5.08 of Atara Biotherapeutics, Inc.6
- Mar 2, 2026Sold 1,603 shares at $5.08 of Atara Biotherapeutics, Inc.6
- Mar 2, 2026Sold 24 shares at $5.08 of Atara Biotherapeutics, Inc.6
- Nov 17, 2025Sold 74 shares at $13.19 of Atara Biotherapeutics, Inc.7
- Nov 17, 2025Sold 85 shares at $13.19 of Atara Biotherapeutics, Inc.7
- Nov 17, 2025Sold 1,645 shares at $13.19 of Atara Biotherapeutics, Inc.7
- Aug 18, 2025Sold 1,668 shares at $11.61 of Atara Biotherapeutics, Inc.8
- Aug 18, 2025Sold 86 shares at $11.61 of Atara Biotherapeutics, Inc.8
- Aug 18, 2025Sold 55 shares at $11.61 of Atara Biotherapeutics, Inc.8
- May 16, 2025Sold 2,218 shares at $6.76 of Atara Biotherapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 11, 2026
- 6SEC EDGARForm 4 filed Mar 4, 2026
- 7SEC EDGARForm 4 filed Nov 19, 2025
- 8SEC EDGARForm 4 filed Aug 20, 2025
- 9SEC EDGARForm 4 filed May 20, 2025